Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SERRAPEPTASE: 28 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
28
Total FAERS Reports
3 (10.7%)
Deaths Reported
8
Hospitalizations
28
As Primary/Secondary Suspect
3
Life-Threatening
2
Disabilities

First Report: 2009 · Latest Report: 20241104

What Are the Most Common SERRAPEPTASE Side Effects?

#1 Most Reported
Headache
13 reports (46.4%)
#2 Most Reported
Dizziness
12 reports (42.9%)
#3 Most Reported
Nausea
9 reports (32.1%)

All SERRAPEPTASE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Headache 13 46.4% 2 2
Dizziness 12 42.9% 2 2
Nausea 9 32.1% 2 4
Fatigue 7 25.0% 2 2
Loss of consciousness 6 21.4% 0 0
Amnesia 5 17.9% 0 0
Asthenia 5 17.9% 0 0
Blood pressure decreased 5 17.9% 0 0
Blood test abnormal 5 17.9% 0 0
Disorientation 5 17.9% 0 0
Fall 5 17.9% 0 0
Gait disturbance 5 17.9% 0 0
Haematocrit decreased 5 17.9% 0 0
Joint injury 5 17.9% 0 0
Joint swelling 5 17.9% 0 0
Ligament sprain 5 17.9% 0 0
Muscular weakness 5 17.9% 0 0
Nervousness 5 17.9% 0 0
Orthostatic hypotension 5 17.9% 0 0
Tremor 5 17.9% 0 0

Who Reports SERRAPEPTASE Side Effects? Age & Gender Data

Gender: 40.0% female, 60.0% male. Average age: 50.4 years. Most reports from: SG. View detailed demographics →

Is SERRAPEPTASE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2009 5 0 0
2012 1 0 0
2014 2 1 1
2015 1 0 0
2016 1 0 0
2019 2 0 0
2021 1 0 0
2022 2 2 2
2024 2 0 1

View full timeline →

What Is SERRAPEPTASE Used For?

IndicationReports
Product used for unknown indication 18

Official FDA Label for SERRAPEPTASE

Official prescribing information from the FDA-approved drug label.